enGene Holdings Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENGN and other ETFs, options, and stocks.About ENGN
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
CEORonald Harold Wilfred Cooper
CEORonald Harold Wilfred Cooper
Employees82
Employees82
HeadquartersSaint-Laurent, Québec
HeadquartersSaint-Laurent, Québec
Founded2023
Founded2023
Employees82
Employees82
ENGN Key Statistics
Market cap588.13M
Market cap588.13M
Price-Earnings ratio-3.84
Price-Earnings ratio-3.84
Dividend yield—
Dividend yield—
Average volume220.79K
Average volume220.79K
High today$9.20
High today$9.20
Low today$8.43
Low today$8.43
Open price$8.54
Open price$8.54
Volume446.06K
Volume446.06K
52 Week high$11.14
52 Week high$11.14
52 Week low$2.65
52 Week low$2.65
Stock Snapshot
With a market cap of 588.13M, enGene Holdings Inc.(ENGN) trades at $8.56. The stock has a price-to-earnings ratio of -3.84.
On 2026-01-11, enGene Holdings Inc.(ENGN) stock traded between a low of $8.43 and a high of $9.20. Shares are currently priced at $8.56, which is +1.6% above the low and -6.9% below the high.
enGene Holdings Inc.(ENGN) shares are trading with a volume of 446.06K, against a daily average of 220.79K.
During the past year, enGene Holdings Inc.(ENGN) stock moved between $2.65 at its lowest and $11.14 at its peak.
During the past year, enGene Holdings Inc.(ENGN) stock moved between $2.65 at its lowest and $11.14 at its peak.
Analyst ratings
91%
of 11 ratingsBuy
90.9%
Hold
9.1%
Sell
0%
People also own
Based on the portfolios of people who own ENGN. This list is generated using Robinhood data, and it’s not a recommendation.